BioAge Labs, Inc. Common Stock

BIOANASDAQ • USD
ThemeLongevity & Aging›Age-Related Therapeutics
11.27 USD
↗ 0.29 (2.64%)AT CLOSE (11:59 AM EDT)
11.30
↗ 0.03 (0.27%)
POST MARKET (AS OF 07:52 PM EDT)
Post Market
AS OF 07:52 PM EDT
11.30
↗ 0.03 (0.27%)
🔴Market: CLOSED

Shares of BioAge Labs, Inc. Common Stock (BIOA) are trading at $11.22. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. On valuation, BIOA trades roughly in line with sector averages — neither particularly cheap nor expensive.

Technical & fundamental data as of Aug 6, 2026.

Open?$10.90
High?$11.37
Low?$10.50
Prev. Close?$10.98
Volume?844.7K
Avg. Volume?1.2M
VWAP?$10.90
Rel. Volume?0.70x
Bid / Ask
Bid?$11.27 × 500
Ask?$11.33 × 3.0K
Spread?$0.06
Midpoint?$11.30
Valuation & Ratios
Market Cap?488.1M
Shares Out?44.5M
Float?31.5M
Float %?70.9%
P/E Ratio?N/A
P/B Ratio?1.30
EPS?-$2.13
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging. The company's technology platform and differentiated human datasets enable the identification of targets based on insights into molecular changes that drive aging. The Company operates and manages its business as one reportable and operating segment, which is the business of extending healthy human life by targeting molecular causes of aging.
Themes
Longevity & Aging›Age-Related TherapeuticsBiotech - Drug Development›Metabolic & Cardiometabolic
Employees
62
Market Cap
488.1M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.bioagelabs.com
Listed
2024-09-26
Address
5885 HOLLIS STREET
EMERYVILLE, CA 94608
Phone: 510-806-1445
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
100
Momentum?
27
Short Sent.?
50
Piotroski F-Score?0/9Weak
Altman Z-Score?12.04Safe
Confidence?45%Low
Full Fundamental Analysis →
Short InterestElevated
Short % of Float?7.77%Elevated
Short Interest?2.5M
Days to Cover?4.5
Free Float31.5M
Avg Daily Volume540.4K
Settlement Date2026-07-15
Financial Health
Current Ratio?17.19Strong
Quick Ratio?17.19Strong
Cash Ratio?3.85Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
Peers
100
S&P
91
1.30CHEAP▾
P/S?
Peers
100
S&P
3
47.14HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-3.9CHEAP▾
EV/Sales?
Peers
100
S&P
3
39.99HIGH▾
Returns & Efficiency
ROE?
S&P
7
-25.2%WEAK▾
ROA?
S&P
3
-23.8%WEAK▾
Cash Flow & Enterprise
FCF?$-88089000
Enterprise Value?$414.1M
Fundamentals ratios updated end of day
MarketsMoversWatchlist